Structure

Physi-Chem Properties

Molecular Weight:  448.1
Volume:  413.147
LogP:  1.513
LogD:  0.048
LogS:  -3.83
# Rotatable Bonds:  3
TPSA:  190.28
# H-Bond Aceptor:  11
# H-Bond Donor:  7
# Rings:  4
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.276
Synthetic Accessibility Score:  4.048
Fsp3:  0.286
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.291
MDCK Permeability:  8.889109267329331e-06
Pgp-inhibitor:  0.03
Pgp-substrate:  0.994
Human Intestinal Absorption (HIA):  0.732
20% Bioavailability (F20%):  0.019
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.009
Plasma Protein Binding (PPB):  93.0771484375%
Volume Distribution (VD):  0.728
Pgp-substrate:  13.413212776184082%

ADMET: Metabolism

CYP1A2-inhibitor:  0.248
CYP1A2-substrate:  0.083
CYP2C19-inhibitor:  0.027
CYP2C19-substrate:  0.055
CYP2C9-inhibitor:  0.106
CYP2C9-substrate:  0.206
CYP2D6-inhibitor:  0.082
CYP2D6-substrate:  0.161
CYP3A4-inhibitor:  0.051
CYP3A4-substrate:  0.012

ADMET: Excretion

Clearance (CL):  4.102
Half-life (T1/2):  0.804

ADMET: Toxicity

hERG Blockers:  0.057
Human Hepatotoxicity (H-HT):  0.089
Drug-inuced Liver Injury (DILI):  0.964
AMES Toxicity:  0.766
Rat Oral Acute Toxicity:  0.037
Maximum Recommended Daily Dose:  0.041
Skin Sensitization:  0.951
Carcinogencity:  0.066
Eye Corrosion:  0.003
Eye Irritation:  0.816
Respiratory Toxicity:  0.104

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC226294

Natural Product ID:  NPC226294
Common Name*:   2-(3,4-Dihydroxyphenyl)-5,6-dihydroxy-7-(alpha-L-rhamnopyranosyloxy)-4H-1-benzopyran-4-one
IUPAC Name:   2-(3,4-dihydroxyphenyl)-5,6-dihydroxy-7-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one
Synonyms:  
Standard InCHIKey:  WBSLGYBCKVSSQR-DGZYFPJZSA-N
Standard InCHI:  InChI=1S/C21H20O11/c1-7-16(25)19(28)20(29)21(30-7)32-14-6-13-15(18(27)17(14)26)11(24)5-12(31-13)8-2-3-9(22)10(23)4-8/h2-7,16,19-23,25-29H,1H3/t7-,16-,19+,20+,21-/m0/s1
SMILES:  C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(C(=C3C(=C2)OC(=CC3=O)C4=CC(=C(C=C4)O)O)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   49798951
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003533] Flavonoid-7-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20259 Vriesea sanguinolenta Species Bromeliaceae Eukaryota n.a. n.a. n.a. PMID[19299148]
NPO20259 Vriesea sanguinolenta Species Bromeliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT485 Organism Plasmodium falciparum (isolate K1 / Thailand) Plasmodium falciparum K1 IC50 = 2130 nM PMID[19299148]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 3320 nM PMID[19299148]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC226294 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC201292
1.0 High Similarity NPC45638
1.0 High Similarity NPC58053
1.0 High Similarity NPC469931
1.0 High Similarity NPC186807
1.0 High Similarity NPC105025
1.0 High Similarity NPC93337
1.0 High Similarity NPC475942
0.9937 High Similarity NPC146792
0.9937 High Similarity NPC58716
0.9937 High Similarity NPC45618
0.9875 High Similarity NPC307518
0.9875 High Similarity NPC48773
0.9875 High Similarity NPC211594
0.9875 High Similarity NPC476405
0.9875 High Similarity NPC172807
0.9875 High Similarity NPC205076
0.9875 High Similarity NPC117260
0.9875 High Similarity NPC254540
0.9814 High Similarity NPC204693
0.9814 High Similarity NPC101026
0.9814 High Similarity NPC24043
0.9814 High Similarity NPC169977
0.9814 High Similarity NPC42773
0.9814 High Similarity NPC45522
0.9814 High Similarity NPC21666
0.9812 High Similarity NPC21190
0.9812 High Similarity NPC22195
0.9812 High Similarity NPC282987
0.9812 High Similarity NPC105511
0.9812 High Similarity NPC245014
0.9812 High Similarity NPC183357
0.9812 High Similarity NPC224462
0.9812 High Similarity NPC84265
0.981 High Similarity NPC22832
0.981 High Similarity NPC311830
0.9753 High Similarity NPC477848
0.9752 High Similarity NPC3583
0.9752 High Similarity NPC259152
0.975 High Similarity NPC170675
0.975 High Similarity NPC472381
0.975 High Similarity NPC210042
0.975 High Similarity NPC471457
0.975 High Similarity NPC95855
0.975 High Similarity NPC472383
0.975 High Similarity NPC112755
0.9748 High Similarity NPC99957
0.9748 High Similarity NPC181616
0.9747 High Similarity NPC222936
0.9747 High Similarity NPC309025
0.9747 High Similarity NPC270335
0.9747 High Similarity NPC243930
0.9747 High Similarity NPC88023
0.9747 High Similarity NPC19709
0.9747 High Similarity NPC94777
0.9747 High Similarity NPC284960
0.9747 High Similarity NPC191306
0.9693 High Similarity NPC169733
0.9693 High Similarity NPC233994
0.9693 High Similarity NPC472385
0.9693 High Similarity NPC198324
0.9693 High Similarity NPC211532
0.9691 High Similarity NPC239549
0.9691 High Similarity NPC236191
0.9691 High Similarity NPC51774
0.9689 High Similarity NPC34287
0.9689 High Similarity NPC474434
0.9689 High Similarity NPC471416
0.9689 High Similarity NPC44558
0.9688 High Similarity NPC93099
0.9688 High Similarity NPC229729
0.9688 High Similarity NPC135345
0.9684 High Similarity NPC189142
0.9684 High Similarity NPC473043
0.9684 High Similarity NPC77660
0.9634 High Similarity NPC168584
0.9632 High Similarity NPC115760
0.9632 High Similarity NPC210094
0.9632 High Similarity NPC264735
0.9632 High Similarity NPC135277
0.9632 High Similarity NPC49344
0.9632 High Similarity NPC472607
0.9632 High Similarity NPC101191
0.9632 High Similarity NPC237435
0.9632 High Similarity NPC43211
0.963 High Similarity NPC301683
0.963 High Similarity NPC472386
0.963 High Similarity NPC267254
0.9627 High Similarity NPC195257
0.9627 High Similarity NPC229687
0.9627 High Similarity NPC223747
0.9627 High Similarity NPC120099
0.9627 High Similarity NPC219904
0.9627 High Similarity NPC183036
0.9627 High Similarity NPC209296
0.9627 High Similarity NPC225434
0.9627 High Similarity NPC203050
0.9625 High Similarity NPC210073
0.9625 High Similarity NPC236934
0.9625 High Similarity NPC5778
0.9625 High Similarity NPC21100
0.9625 High Similarity NPC115674
0.9625 High Similarity NPC197285
0.9623 High Similarity NPC168822
0.9623 High Similarity NPC88043
0.962 High Similarity NPC182045
0.9576 High Similarity NPC126784
0.9576 High Similarity NPC241423
0.9576 High Similarity NPC470444
0.9576 High Similarity NPC473571
0.9576 High Similarity NPC470443
0.9576 High Similarity NPC110941
0.9576 High Similarity NPC473682
0.9573 High Similarity NPC472992
0.9573 High Similarity NPC65563
0.9573 High Similarity NPC472991
0.9573 High Similarity NPC8573
0.9573 High Similarity NPC470949
0.9571 High Similarity NPC4390
0.9568 High Similarity NPC206123
0.9568 High Similarity NPC231194
0.9568 High Similarity NPC51326
0.9565 High Similarity NPC84362
0.9565 High Similarity NPC52550
0.9565 High Similarity NPC226304
0.9565 High Similarity NPC317489
0.9565 High Similarity NPC116745
0.9565 High Similarity NPC127546
0.9565 High Similarity NPC265530
0.9565 High Similarity NPC173637
0.9565 High Similarity NPC45400
0.9565 High Similarity NPC325555
0.9565 High Similarity NPC223424
0.9563 High Similarity NPC277205
0.9563 High Similarity NPC165720
0.956 High Similarity NPC300537
0.956 High Similarity NPC127782
0.9557 High Similarity NPC110349
0.9518 High Similarity NPC473073
0.9518 High Similarity NPC473071
0.9512 High Similarity NPC102028
0.9512 High Similarity NPC142996
0.9509 High Similarity NPC475155
0.9509 High Similarity NPC256760
0.9509 High Similarity NPC153755
0.9509 High Similarity NPC235575
0.9509 High Similarity NPC190003
0.9509 High Similarity NPC156977
0.9509 High Similarity NPC175107
0.9506 High Similarity NPC86008
0.9506 High Similarity NPC471287
0.9503 High Similarity NPC179950
0.9503 High Similarity NPC135599
0.9503 High Similarity NPC88789
0.9503 High Similarity NPC56077
0.9503 High Similarity NPC276222
0.9503 High Similarity NPC253662
0.9503 High Similarity NPC308404
0.9503 High Similarity NPC8856
0.9503 High Similarity NPC118284
0.9503 High Similarity NPC328940
0.9503 High Similarity NPC281131
0.9503 High Similarity NPC113968
0.9503 High Similarity NPC274618
0.9503 High Similarity NPC277174
0.9503 High Similarity NPC145038
0.9503 High Similarity NPC73855
0.95 High Similarity NPC29830
0.9461 High Similarity NPC36138
0.9461 High Similarity NPC470449
0.9461 High Similarity NPC470447
0.9461 High Similarity NPC470445
0.9461 High Similarity NPC470446
0.9461 High Similarity NPC473072
0.9455 High Similarity NPC257714
0.9455 High Similarity NPC472380
0.9455 High Similarity NPC472384
0.9455 High Similarity NPC268533
0.9455 High Similarity NPC472382
0.9451 High Similarity NPC172033
0.9451 High Similarity NPC472993
0.9451 High Similarity NPC175230
0.9451 High Similarity NPC88560
0.9451 High Similarity NPC208668
0.9448 High Similarity NPC150767
0.9448 High Similarity NPC20505
0.9448 High Similarity NPC44328
0.9448 High Similarity NPC177731
0.9448 High Similarity NPC293004
0.9448 High Similarity NPC67105
0.9448 High Similarity NPC155763
0.9448 High Similarity NPC212748
0.9448 High Similarity NPC244776
0.9448 High Similarity NPC105095
0.9448 High Similarity NPC204937
0.9448 High Similarity NPC79056
0.9448 High Similarity NPC78734
0.9448 High Similarity NPC116864
0.9448 High Similarity NPC95866
0.9448 High Similarity NPC149011

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC226294 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9632 High Similarity NPD4338 Clinical (unspecified phase)
0.9627 High Similarity NPD7054 Approved
0.9568 High Similarity NPD7472 Approved
0.9448 High Similarity NPD7074 Phase 3
0.9444 High Similarity NPD3818 Discontinued
0.939 High Similarity NPD6797 Phase 2
0.9333 High Similarity NPD7251 Discontinued
0.9277 High Similarity NPD7808 Phase 3
0.9241 High Similarity NPD2801 Approved
0.9187 High Similarity NPD4381 Clinical (unspecified phase)
0.9057 High Similarity NPD1934 Approved
0.897 High Similarity NPD6166 Phase 2
0.897 High Similarity NPD6167 Clinical (unspecified phase)
0.897 High Similarity NPD6168 Clinical (unspecified phase)
0.8882 High Similarity NPD2393 Clinical (unspecified phase)
0.881 High Similarity NPD7804 Clinical (unspecified phase)
0.8712 High Similarity NPD3817 Phase 2
0.8671 High Similarity NPD1511 Approved
0.8659 High Similarity NPD4868 Clinical (unspecified phase)
0.8659 High Similarity NPD3882 Suspended
0.858 High Similarity NPD4380 Phase 2
0.8562 High Similarity NPD1512 Approved
0.8503 High Similarity NPD5494 Approved
0.8485 Intermediate Similarity NPD5402 Approved
0.8457 Intermediate Similarity NPD1653 Approved
0.8439 Intermediate Similarity NPD6559 Discontinued
0.8276 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8274 Intermediate Similarity NPD7075 Discontinued
0.8266 Intermediate Similarity NPD5844 Phase 1
0.8176 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD6801 Discontinued
0.8125 Intermediate Similarity NPD7685 Pre-registration
0.8125 Intermediate Similarity NPD1549 Phase 2
0.8122 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD1465 Phase 2
0.8081 Intermediate Similarity NPD6232 Discontinued
0.8061 Intermediate Similarity NPD5403 Approved
0.8047 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8046 Intermediate Similarity NPD7473 Discontinued
0.8011 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD3751 Discontinued
0.8 Intermediate Similarity NPD2796 Approved
0.8 Intermediate Similarity NPD7228 Approved
0.7988 Intermediate Similarity NPD7819 Suspended
0.7988 Intermediate Similarity NPD6799 Approved
0.7977 Intermediate Similarity NPD3787 Discontinued
0.7976 Intermediate Similarity NPD7411 Suspended
0.7952 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD5401 Approved
0.7937 Intermediate Similarity NPD1510 Phase 2
0.7919 Intermediate Similarity NPD7199 Phase 2
0.7919 Intermediate Similarity NPD6959 Discontinued
0.7907 Intermediate Similarity NPD6234 Discontinued
0.7845 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7833 Intermediate Similarity NPD8313 Approved
0.7833 Intermediate Similarity NPD8312 Approved
0.7824 Intermediate Similarity NPD37 Approved
0.7819 Intermediate Similarity NPD6780 Approved
0.7819 Intermediate Similarity NPD6776 Approved
0.7819 Intermediate Similarity NPD6779 Approved
0.7819 Intermediate Similarity NPD6781 Approved
0.7819 Intermediate Similarity NPD6777 Approved
0.7819 Intermediate Similarity NPD6778 Approved
0.7819 Intermediate Similarity NPD6782 Approved
0.7816 Intermediate Similarity NPD1247 Approved
0.7805 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD1613 Approved
0.7791 Intermediate Similarity NPD4966 Approved
0.7791 Intermediate Similarity NPD4965 Approved
0.7791 Intermediate Similarity NPD4967 Phase 2
0.773 Intermediate Similarity NPD7266 Discontinued
0.7727 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7706 Intermediate Similarity NPD6599 Discontinued
0.7696 Intermediate Similarity NPD7435 Discontinued
0.7688 Intermediate Similarity NPD1240 Approved
0.7688 Intermediate Similarity NPD943 Approved
0.7684 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7668 Intermediate Similarity NPD7584 Approved
0.7665 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD6190 Approved
0.764 Intermediate Similarity NPD230 Phase 1
0.764 Intermediate Similarity NPD1933 Approved
0.7627 Intermediate Similarity NPD3926 Phase 2
0.761 Intermediate Similarity NPD3027 Phase 3
0.7604 Intermediate Similarity NPD7698 Approved
0.7604 Intermediate Similarity NPD7696 Phase 3
0.7604 Intermediate Similarity NPD7697 Approved
0.7602 Intermediate Similarity NPD7783 Phase 2
0.7602 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD919 Approved
0.7593 Intermediate Similarity NPD1607 Approved
0.759 Intermediate Similarity NPD8151 Discontinued
0.759 Intermediate Similarity NPD3750 Approved
0.7565 Intermediate Similarity NPD7870 Phase 2
0.7565 Intermediate Similarity NPD7871 Phase 2
0.7561 Intermediate Similarity NPD2935 Discontinued
0.7553 Intermediate Similarity NPD6535 Approved
0.7553 Intermediate Similarity NPD6534 Approved
0.7552 Intermediate Similarity NPD6823 Phase 2
0.7547 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD3749 Approved
0.7538 Intermediate Similarity NPD7701 Phase 2
0.7531 Intermediate Similarity NPD447 Suspended
0.7527 Intermediate Similarity NPD7240 Approved
0.7486 Intermediate Similarity NPD7768 Phase 2
0.7485 Intermediate Similarity NPD4628 Phase 3
0.7484 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD8455 Phase 2
0.7462 Intermediate Similarity NPD7874 Approved
0.7462 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD1551 Phase 2
0.7453 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7435 Intermediate Similarity NPD7699 Phase 2
0.7435 Intermediate Similarity NPD7700 Phase 2
0.7424 Intermediate Similarity NPD7801 Approved
0.7414 Intermediate Similarity NPD6844 Discontinued
0.7412 Intermediate Similarity NPD2532 Approved
0.7412 Intermediate Similarity NPD2534 Approved
0.7412 Intermediate Similarity NPD2533 Approved
0.7358 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD920 Approved
0.7321 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD2800 Approved
0.7316 Intermediate Similarity NPD6212 Phase 3
0.7316 Intermediate Similarity NPD6213 Phase 3
0.7316 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD3748 Approved
0.7283 Intermediate Similarity NPD5953 Discontinued
0.7273 Intermediate Similarity NPD7585 Approved
0.7267 Intermediate Similarity NPD9494 Approved
0.7241 Intermediate Similarity NPD3226 Approved
0.7234 Intermediate Similarity NPD8434 Phase 2
0.7234 Intermediate Similarity NPD8150 Discontinued
0.7222 Intermediate Similarity NPD7583 Approved
0.7219 Intermediate Similarity NPD6674 Discontinued
0.7216 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD1091 Approved
0.7209 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7204 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD4363 Phase 3
0.7188 Intermediate Similarity NPD4360 Phase 2
0.7186 Intermediate Similarity NPD7033 Discontinued
0.7174 Intermediate Similarity NPD7286 Phase 2
0.7157 Intermediate Similarity NPD7680 Approved
0.7143 Intermediate Similarity NPD6099 Approved
0.7143 Intermediate Similarity NPD7458 Discontinued
0.7143 Intermediate Similarity NPD6100 Approved
0.7135 Intermediate Similarity NPD5353 Approved
0.7134 Intermediate Similarity NPD2313 Discontinued
0.7125 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD8320 Phase 1
0.7121 Intermediate Similarity NPD8319 Approved
0.7118 Intermediate Similarity NPD1652 Phase 2
0.7118 Intermediate Similarity NPD1243 Approved
0.7117 Intermediate Similarity NPD6832 Phase 2
0.7117 Intermediate Similarity NPD4908 Phase 1
0.7101 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD2346 Discontinued
0.7101 Intermediate Similarity NPD2344 Approved
0.7099 Intermediate Similarity NPD2798 Approved
0.7093 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD6233 Phase 2
0.7083 Intermediate Similarity NPD2799 Discontinued
0.7066 Intermediate Similarity NPD6651 Approved
0.7052 Intermediate Similarity NPD7390 Discontinued
0.7049 Intermediate Similarity NPD5242 Approved
0.7037 Intermediate Similarity NPD1203 Approved
0.703 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD7549 Discontinued
0.702 Intermediate Similarity NPD5006 Approved
0.702 Intermediate Similarity NPD5005 Approved
0.7011 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5124 Phase 1
0.7006 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.6995 Remote Similarity NPD5710 Approved
0.6995 Remote Similarity NPD5711 Approved
0.6982 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6977 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6966 Remote Similarity NPD6386 Approved
0.6966 Remote Similarity NPD6385 Approved
0.6966 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6962 Remote Similarity NPD1548 Phase 1
0.6957 Remote Similarity NPD9269 Phase 2
0.6952 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6951 Remote Similarity NPD2861 Phase 2
0.6949 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6947 Remote Similarity NPD7090 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data